Purpose: There remain uncertainties due to inter-and intraobserver variability in soft-tissue-based patient positioning even with the use of image-guided radiation therapy (IGRT). This study aimed to reveal observer uncertainties of soft-tissuebased patient positioning on cone-beam computed tomography (CBCT) images for prostate cancer IGRT.
| INTRODUCTION
Prostate cancer is the most frequently diagnosed cancer in males. Approximately 1.3 million new cases of prostate cancer and 359 000 associated deaths were reported worldwide in 2018. 1 Common approaches for treating localized prostate cancer include active surveillance, radical prostatectomy, radiotherapy, and hormonal therapy. 2 Since external beam radiation therapy (a minimal dose of 72 Gy) showed similar biochemical relapse-free survival rates of localized prostate cancer as radical prostatectomy, 3 radiation therapy has an advantage for elderly people, who cannot undergo surgery due to complications. 2, 3 In the current radiation therapy for prostate cancer, imageguided radiation therapy (IGRT) with cone-beam computed tomography (CBCT) images has been commonly used in clinical practice to increase the accuracy of patient positioning. 4 Zelefsky et al. reported that intensity modulated radiotherapy (IMRT) with image-guided patient positioning (IGPP) improved prostatespecific antigen (PSA) outcomes and toxicities of organs at risk (OAR). 5 Soft-tissue-based patient positioning with CBCT images [6] [7] [8] [9] and intraprostatic fiducial marker-based patient positioning [10] [11] [12] have been used for more accurate target-based-patient positioning (TBPP). Soft-tissue-based patient positioning with CBCT images is a noninvasive approach and has the advantage of providing soft-tissue information such as circumstances of targets and critical organs. However, there are uncertainties due to inter-and intraobserver variability, [6] [7] [8] [9] which may influence clinical outcomes and OAR toxicities.
Several studies have assessed inter-and intraobserver variability in soft-tissue-based patient positioning. [6] [7] [8] [9] Some studies have investigated the accuracy of soft-tissue-based patient positioning with CBCT images compared to patient positioning based on fiducial markers for patients undergoing external beam radiotherapy of the prostate. 6, 7 Jereczek-Fossa et al. used online CBCT positioning performed by a radiation oncologist immediately prior to treatment as reference for manual soft-tissuebased patient positioning reviewed by observers. 8 To our knowledge, no observer studies have evaluated inter-and intraobserver variability in soft-tissue-based patient positioning using prostate contours on CBCT images.
We hypothesized that the uncertainties due to inter-and intraobserver variability for soft-tissue-based patient positioning using CBCT images would not be negligible. In this observer study, the uncertainties of soft-tissue-based patient positioning against contour-based patient positioning were evaluated by systematic and random errors of inter-and intraobserver variability in anterior-posterior (AP), superior-inferior (SI), and left-right (LR) directions. Then, clinical target volume (CTV)-to-planning target volume (PTV) margins for the soft-tissue-based patient positioning were calculated from the systematic and random errors of the inter-and intraobserver variations.
| MATERIALS AND METHODS

2.A | Overall evaluation scheme of uncertainties for soft-tissue-based patient positioning
The uncertainties for soft-tissue-based patient positioning were evaluated by inter-and intraobserver variations. The interobserver variations were obtained from residual errors, which denote differences between soft-tissue positioning errors and reference positioning errors. The evaluation scheme of residual errors by each observer for a fraction is illustrated in Fig. 1 . The reference positioning errors were obtained from prostate cancer location errors (PCLEs) of contour-based patient positioning between planning CT (pCT) and pretreatment CBCT (pre-CBCT) images. The PCLEs of contour-based patient positioning indicate the centroid distance of prostate contours on pCT and pre-CBCT images. The soft-tissue positioning errors were measured from the PCLEs of soft-tissue-based patient positioning in the observer study, which were performed between pCT and pre-CBCT images after an automatic bone-based registration by six observers. Then, the intraobserver variations were evaluated from the differences between the first and second soft-tissuebased patient positioning repeated by the same observer for each fraction. Finally, CTV-to-PTV margins (hereafter PTV margins) were calculated from the systematic and random errors of the inter-and intraobserver variations in AP, SI, and LR directions. 
2.B | Patient data and setup
2.F | Interobserver variations
Inter-observer variations were evaluated from the residual errors, which denoted the differences between the soft-tissue positioning errors and reference positioning errors for each fraction. The systematic error (ɛ inter ) and random error (σ inter ) for interobserver variations were calculated from the root mean square (RMS) of the residual errors by N observers, respectively, as
The evaluation scheme of residual errors by each observer on pre-cone-beam computed tomography image of a fraction.
and
where N is the number of observers. ɛ inter;j and σ inter;j represent systematic and random errors of the residual errors for an observer j, respectively. The systematic error (ɛ inter;j ) and random error (σ inter;j )
for an observer j were given by
respectively,where n is number of patients. m inter;i;j and m inter;j represent the mean residual error of a patient i by an observer j and the mean residual error of all patients by the observer j, respectively. σ inter;i;j represents the SD of the residual error of a patient i by an observer j. m inter;i;j and m inter;j are given by
where F is the number of fractions. d inter;i;j;k represents the residual error at a fraction k of a patient i by an observer j, which denotes the difference between a soft-tissue positioning error and reference positioning error at each fraction.
2.G | Intraobserver variations
To further explore the effect of intraobserver variations in soft-tissue-based patient positioning on prostate IGRT, each observer repeated the soft-tissue-based patient positioning process for the same cases 3 months later. An intraobserver variation was evaluated as the difference between the first and second soft-tissue-based patient positionings repeated by an observer at each fraction of a patient. Five observers participated in the observer study with ten patients. The systematic error (ɛ intra ) and random error (σ intra ) for intraobserver variations were calculated from the RMS of the intraobserver errors by N observers, respectively, as
where N is the number of observers. ɛ intra;j and σ intra;j represent systematic and random errors of the intraobserver errors for an observer j, respectively. The systematic error (ɛ intra;j ) and random error (σ intra;j ) for an observer j were given by
where n is number of patients. m intra;i;j and m intra;j represent the mean intraobserver error of a patient i by an observer j and mean intraobserver error of all patients by the observer j, respectively. σ intra;i;j represents SD of the intraobserver errors of a patient i by the observer j. m intra;i;j and m intra;j are given by
where F is the number of fractions. d intra;i;j;k represents the intraobserver error at a fraction k of a patient i by an observer j, which denotes the difference between the first and second soft-tissuebased patient positioning repeated by an observer at each fraction of a patient.
2.H | PTV margin calculations
Planning target volume margins were calculated from the systematic and random errors of interobserver and/or intraobserver variations using the van Herk's margin formula, 14 as follows:
This formula was derived based on a dose-population histogram to deliver at least 95% of a prescribed dose to 90% of a patient population. The RMSs of the random errors for interobserver variations by the six observers were 1.8, 2.2, and 1.1 mm in AP, SI, and LR directions.
| RESULTS
3.A | Residual errors
3.B | Interobserver variations
3.C | Intraobserver variations
The systematic and random errors of intraobserver variations calculated as the difference between the first and second soft-tissuebased patient positioning repeated by each observer for each fraction were <0.2 mm in AP, SI, and LR directions. These dose evaluation indices were defined based on ICRU report 83 16 as follows:
3.D | PTV margins
where V PTV is the volume of PTV, and V PD98% is the volume receiving 98% of the prescribed dose. D2, D98, and D50 mean the minimum dose that covers 2%, 98%, and 50% of the PTV, respectively. Dose conformity of PTV was significantly greater in the treatment plan with PTV ST than that with PTV CL . There were no statistically significant differences in CTV coverage indices of D98 and D95 between the treatment plans with PTV ST and PTV CL . The OAR doses in the treatment plans with PTV ST showed lower value than those with PTV CL in all dose parameters. The dose coverages to CTV and PTV larger than 90% in the treatment plan with proposed PTV ST were acceptable in clinical practice, and the small PTV margins contributed to OAR dose reduction. Therefore, the PTV margin estimated in this study would be applicable in clinical practice. However, attention should be paid to the determination of PTV margins, because small PTV margins of less than 3 mm may cause lower CTV coverages due to organ deformations and volume changes in actual treatment. 17 Previous studies often used intraprostatic fiducial markers as ref-
erence for soft-tissue-based patient positioning with CBCT images in IGRT for prostate cancer. 6, 7 However, in-migration of these fiducial markers has been observed with a reduction in prostate volume during radiation treatment courses. [18] [19] [20] In addition, Loh et al. reported a F I G . 5. Planning target volume margins calculated from the systematic and random errors of interobserver and/or intraobserver variations in anteriorposterior, superior-inferior, and left-right directions.
high rate of symptomatic infection with fiducial marker implantation and concluded that noninvasive approaches for prostate IGRT, such as CBCT, should be considered. 21 The present study has the advantage that the uncertainties of soft-tissue-based patient positioning were evaluated on pre-CBCT images without fiducial markers.
If same therapists perform soft-tissue-based patient positioning during the entire course of the treatment, the intraobserver variability would be <0.2 mm, which may be negligible. However, there could remain an uncertainty specific to each observer. Therefore, the uncertainty of the observer should be taken into account for calculating PTV margins. Nevertheless, the observer-specific uncertainties can also be evaluated by comparing with the contour-based patient positioning proposed in this study.
Recently, a commercial on-board CBCT equipped with an iterative image reconstruction function has been available. The iterative image reconstruction algorithm can improve the CBCT image quality by reducing noise and artifacts. 22 ments contributed significantly to this study. We would also like to thank Editage (www.editage.com) for English language editing.
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